Back
Open Access

Strategies to improve implementation of evidence-based heart failure treatments - Overcoming clinical inertia

Session: Overcoming clinical inertia in chronic heart failure care - SGLT2 inhibition across the spectrum of ejection fraction
Topic: Chronic Heart Failure
Speaker: Professor A. Mebazaa (Paris, FR)
Sponsored by Charité Friends & Sponsors Trust - Supported by an educational grant from Boehringer Ingelheim & Lilly Alliance
Event: Heart Failure 2023

Congress Presentation

About the speaker

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)
81 presentations
20 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor E. Jankowska (Wroclaw, PL)

Access
Slides
Video
Thumbnail

SGLT2 inhibition across the spectrum of ejection fraction - the time for implementation is now!

Speaker: Professor J. Butler (Dallas, US)

Access
Slides
Video
Thumbnail

Practical guidance for the use of SGLT2 inhibitors in patients with chronic heart failure across the spectrum of ejection fraction

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access
Slides
Video
Thumbnail

Interactive panel discussion

Speaker: Professor E. Jankowska (Wroclaw, PL) Professor S. Anker (Berlin, DE) Professor J. Butler (Dallas, US) Doctor S. Zieroth (Winnipeg, CA) Professor A. Mebazaa (Paris, FR)

Access
Slides
Video
Thumbnail

Conclusion

Speaker: Professor S. Anker (Berlin, DE)

Access
Slides
Thumbnail

Access the full session

Overcoming clinical inertia in chronic heart failure care - SGLT2 inhibition across the spectrum of ejection fraction

Speakers: Professor A. Mebazaa, Professor E. Jankowska, Professor J. Butler, Doctor S. Zieroth, Professor E. Jankowska...
Access
Video
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources